Curcumin modulates gut microbiota and improves renal function in rats with uric acid nephropathy
It is well known that the progression of hyperuricemia disease often contributes to renal dysfunction. However, there have been few studies on uric acid nephropathy (UAN), especially its relationship with gut microbiota. UAN is usually accompanied by disordered intestinal flora, and damaged gut barr...
Saved in:
| Published in: | Renal failure Vol. 43; no. 1; pp. 1063 - 1075 |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
New York
Taylor & Francis
01.01.2021
Taylor & Francis Ltd Taylor & Francis Group |
| Subjects: | |
| ISSN: | 0886-022X, 1525-6049, 1525-6049 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | It is well known that the progression of hyperuricemia disease often contributes to renal dysfunction. However, there have been few studies on uric acid nephropathy (UAN), especially its relationship with gut microbiota. UAN is usually accompanied by disordered intestinal flora, and damaged gut barrier, which are closely related to tubulointerstitial fibrosis, and systemic inflammation. In previous studies, it has been confirmed that curcumin could alleviate tubulointerstitial fibrosis, and improve renal function through its antioxidant, anti-apoptotic, and anti-inflammatory efficacies. However, the effects curcumin exerts on intestinal flora in uric acid nephropathy are still unknown. Therefore, we used next-generation sequencing technology to investigate the effects of curcumin on gut microbiota in a rat model of UAN induced by adenine and potassium oxonate, and rats were randomly divided into control, model or curcumin treatment groups. The results demonstrated that, compared to the model group, the treatment group showed decreased serum uric acid (156.80 ± 11.90 μmol/L vs. 325.60 ± 18.65 μmol/L, p < 0.001), serum creatinine (66.20 ± 11.88 μmol/L vs. 182.20 ± 8.87 μmol/L, p < 0.001) and BUN level (13.33 ± 3.16 mmol/L vs. 36.04 ± 6.60 mmol/L, p < 0.001). The treatment group also displayed attenuated renal pathological lesions and metabolic endotoxemia (25.60 ± 5.90 ng/mL vs. 38.40 ± 4.98 ng/mL, p < 0.01), and improved tightly linked proteins expression. Besides, curcumin altered the gut microbiota structure in UAN rats. More specifically, curcumin treatment protected against the overgrowth of opportunistic pathogens in UAN, including Escherichia-Shigella and Bacteroides, and increased the relative abundance of bacteria producing short-chain fatty acids (SCFAs), such as Lactobacillus and Ruminococcaceae. These results suggest that curcumin could modulate gut microbiota, fortify the intestinal barrier, attenuate metabolic endotoxemia, and consequently protect the renal function in UAN rats. |
|---|---|
| AbstractList | It is well known that the progression of hyperuricemia disease often contributes to renal dysfunction. However, there have been few studies on uric acid nephropathy (UAN), especially its relationship with gut microbiota. UAN is usually accompanied by disordered intestinal flora, and damaged gut barrier, which are closely related to tubulointerstitial fibrosis, and systemic inflammation. In previous studies, it has been confirmed that curcumin could alleviate tubulointerstitial fibrosis, and improve renal function through its antioxidant, anti-apoptotic, and anti-inflammatory efficacies. However, the effects curcumin exerts on intestinal flora in uric acid nephropathy are still unknown. Therefore, we used next-generation sequencing technology to investigate the effects of curcumin on gut microbiota in a rat model of UAN induced by adenine and potassium oxonate, and rats were randomly divided into control, model or curcumin treatment groups. The results demonstrated that, compared to the model group, the treatment group showed decreased serum uric acid (156.80 ± 11.90 μmol/L vs. 325.60 ± 18.65 μmol/L, p < 0.001), serum creatinine (66.20 ± 11.88 μmol/L vs. 182.20 ± 8.87 μmol/L, p < 0.001) and BUN level (13.33 ± 3.16 mmol/L vs. 36.04 ± 6.60 mmol/L, p < 0.001). The treatment group also displayed attenuated renal pathological lesions and metabolic endotoxemia (25.60 ± 5.90 ng/mL vs. 38.40 ± 4.98 ng/mL, p < 0.01), and improved tightly linked proteins expression. Besides, curcumin altered the gut microbiota structure in UAN rats. More specifically, curcumin treatment protected against the overgrowth of opportunistic pathogens in UAN, including Escherichia-Shigella and Bacteroides, and increased the relative abundance of bacteria producing short-chain fatty acids (SCFAs), such as Lactobacillus and Ruminococcaceae. These results suggest that curcumin could modulate gut microbiota, fortify the intestinal barrier, attenuate metabolic endotoxemia, and consequently protect the renal function in UAN rats.It is well known that the progression of hyperuricemia disease often contributes to renal dysfunction. However, there have been few studies on uric acid nephropathy (UAN), especially its relationship with gut microbiota. UAN is usually accompanied by disordered intestinal flora, and damaged gut barrier, which are closely related to tubulointerstitial fibrosis, and systemic inflammation. In previous studies, it has been confirmed that curcumin could alleviate tubulointerstitial fibrosis, and improve renal function through its antioxidant, anti-apoptotic, and anti-inflammatory efficacies. However, the effects curcumin exerts on intestinal flora in uric acid nephropathy are still unknown. Therefore, we used next-generation sequencing technology to investigate the effects of curcumin on gut microbiota in a rat model of UAN induced by adenine and potassium oxonate, and rats were randomly divided into control, model or curcumin treatment groups. The results demonstrated that, compared to the model group, the treatment group showed decreased serum uric acid (156.80 ± 11.90 μmol/L vs. 325.60 ± 18.65 μmol/L, p < 0.001), serum creatinine (66.20 ± 11.88 μmol/L vs. 182.20 ± 8.87 μmol/L, p < 0.001) and BUN level (13.33 ± 3.16 mmol/L vs. 36.04 ± 6.60 mmol/L, p < 0.001). The treatment group also displayed attenuated renal pathological lesions and metabolic endotoxemia (25.60 ± 5.90 ng/mL vs. 38.40 ± 4.98 ng/mL, p < 0.01), and improved tightly linked proteins expression. Besides, curcumin altered the gut microbiota structure in UAN rats. More specifically, curcumin treatment protected against the overgrowth of opportunistic pathogens in UAN, including Escherichia-Shigella and Bacteroides, and increased the relative abundance of bacteria producing short-chain fatty acids (SCFAs), such as Lactobacillus and Ruminococcaceae. These results suggest that curcumin could modulate gut microbiota, fortify the intestinal barrier, attenuate metabolic endotoxemia, and consequently protect the renal function in UAN rats. It is well known that the progression of hyperuricemia disease often contributes to renal dysfunction. However, there have been few studies on uric acid nephropathy (UAN), especially its relationship with gut microbiota. UAN is usually accompanied by disordered intestinal flora, and damaged gut barrier, which are closely related to tubulointerstitial fibrosis, and systemic inflammation. In previous studies, it has been confirmed that curcumin could alleviate tubulointerstitial fibrosis, and improve renal function through its antioxidant, anti-apoptotic, and anti-inflammatory efficacies. However, the effects curcumin exerts on intestinal flora in uric acid nephropathy are still unknown. Therefore, we used next-generation sequencing technology to investigate the effects of curcumin on gut microbiota in a rat model of UAN induced by adenine and potassium oxonate, and rats were randomly divided into control, model or curcumin treatment groups. The results demonstrated that, compared to the model group, the treatment group showed decreased serum uric acid (156.80 ± 11.90 μmol/L vs. 325.60 ± 18.65 μmol/L, p < 0.001), serum creatinine (66.20 ± 11.88 μmol/L vs. 182.20 ± 8.87 μmol/L, p < 0.001) and BUN level (13.33 ± 3.16 mmol/L vs. 36.04 ± 6.60 mmol/L, p < 0.001). The treatment group also displayed attenuated renal pathological lesions and metabolic endotoxemia (25.60 ± 5.90 ng/mL vs. 38.40 ± 4.98 ng/mL, p < 0.01), and improved tightly linked proteins expression. Besides, curcumin altered the gut microbiota structure in UAN rats. More specifically, curcumin treatment protected against the overgrowth of opportunistic pathogens in UAN, including Escherichia-Shigella and Bacteroides, and increased the relative abundance of bacteria producing short‐chain fatty acids (SCFAs), such as Lactobacillus and Ruminococcaceae. These results suggest that curcumin could modulate gut microbiota, fortify the intestinal barrier, attenuate metabolic endotoxemia, and consequently protect the renal function in UAN rats. |
| Author | Man, Xiaofei Liu, Xuemei Luo, Congjuan Zhen, Li Xu, Xueling Wang, Huifang Guo, Dandan Li, Junying Liu, Jun Zhang, Ming |
| Author_xml | – sequence: 1 givenname: Xueling surname: Xu fullname: Xu, Xueling organization: Department of Nephrology, The Affiliated Hospital of Qingdao University – sequence: 2 givenname: Huifang surname: Wang fullname: Wang, Huifang organization: Department of Nephrology, The Affiliated Hospital of Qingdao University – sequence: 3 givenname: Dandan surname: Guo fullname: Guo, Dandan organization: Department of Nephrology, The Affiliated Hospital of Qingdao University – sequence: 4 givenname: Xiaofei surname: Man fullname: Man, Xiaofei organization: Department of Nephrology, The Affiliated Hospital of Qingdao University – sequence: 5 givenname: Jun surname: Liu fullname: Liu, Jun organization: Department of Nephrology, The Affiliated Hospital of Qingdao University – sequence: 6 givenname: Junying surname: Li fullname: Li, Junying organization: Department of Nephrology, The Affiliated Hospital of Qingdao University – sequence: 7 givenname: Congjuan surname: Luo fullname: Luo, Congjuan organization: Department of Nephrology, The Affiliated Hospital of Qingdao University – sequence: 8 givenname: Ming surname: Zhang fullname: Zhang, Ming organization: Department of Nephrology, The Affiliated Hospital of Qingdao University – sequence: 9 givenname: Li surname: Zhen fullname: Zhen, Li organization: Department of Nephrology, The Affiliated Hospital of Qingdao University – sequence: 10 givenname: Xuemei surname: Liu fullname: Liu, Xuemei organization: Department of Nephrology, The Affiliated Hospital of Qingdao University |
| BookMark | eNqFkkuLFDEUhYOMOA_9CULAjZtuk1SlkiCIQ-NjYMCNgrt4K0l1p6lK2iQ1Q_9703YrzCx0lZD7ncMh91yisxCDQ-glJUtKJHlDpOwIY9-XjDC6pKptpeBP0AXljC860qozdHFgFgfoHF3mvCWEcinYM3TetLReFLtAP1ZzMvPkA56inUcoLuP1XPDkTYq9jwUwBIv9tEvxrs6SCzDiYQ6m-Bhw1SUoGd_7ssFz8gaD8RYHt9ukuIOy2T9HTwcYs3txOq_Qt48fvq4-L26_fLpZXd8uDG9UWfQ97buOKGpaKmjNqayRHSeWNYOkYAQlTjTScgkOBt67QXTCUFIHTBHXN1fo5uhrI2z1LvkJ0l5H8Pr3Q0xrDal4MzotuGp7a4yiFFqnKBDZCTuABeqappfV693Razf3k7PGhZJgfGD6cBL8Rq_jnZaMN1R21eD1ySDFn7PLRU8-GzeOEFycs2a87ZQktGMVffUI3cY51U-ulGCUKCFUWyl-pOpWck5u-BuGEn3og_7TB33ogz71oerePtIZX-Cwuprbj_9Vvz-qfRhimuA-ptHqAvsxpiFBMD7r5t8WvwBA_tDJ |
| CitedBy_id | crossref_primary_10_1007_s00203_022_03053_y crossref_primary_10_3389_fcimb_2022_1051682 crossref_primary_10_3389_fphar_2023_1115224 crossref_primary_10_1039_D5FO01404B crossref_primary_10_1111_cbdd_14367 crossref_primary_10_3389_fnut_2022_960309 crossref_primary_10_3390_nu16203530 crossref_primary_10_3390_ijms24021095 crossref_primary_10_3389_fphar_2022_1026246 crossref_primary_10_3389_fcimb_2022_887407 crossref_primary_10_3389_fnut_2024_1407736 crossref_primary_10_1097_IMNA_D_24_00068 crossref_primary_10_3389_fcimb_2024_1483550 crossref_primary_10_1007_s00280_021_04385_0 crossref_primary_10_1016_j_phanu_2025_100450 crossref_primary_10_1016_j_fbio_2025_105944 crossref_primary_10_3389_fmicb_2025_1654152 crossref_primary_10_1016_j_envpol_2023_121335 crossref_primary_10_1016_j_phymed_2024_156335 crossref_primary_10_3390_nu14122498 crossref_primary_10_3390_toxins14100648 crossref_primary_10_2147_JIR_S499343 crossref_primary_10_1002_mnfr_70097 crossref_primary_10_1016_j_phymed_2022_154110 crossref_primary_10_1186_s12964_024_01922_1 crossref_primary_10_3390_ijms251910692 crossref_primary_10_1016_j_scitotenv_2022_160321 crossref_primary_10_1186_s12986_025_00977_2 crossref_primary_10_1016_j_ijpharm_2023_123683 crossref_primary_10_1007_s40263_022_00901_9 crossref_primary_10_1016_j_psep_2024_04_121 crossref_primary_10_1016_j_scitotenv_2023_167696 crossref_primary_10_1016_j_phymed_2023_154979 crossref_primary_10_3390_nu15081989 crossref_primary_10_1186_s12263_025_00766_9 crossref_primary_10_1039_D2FO03332A crossref_primary_10_1016_j_phrs_2023_106787 crossref_primary_10_1002_jsfa_13677 crossref_primary_10_1016_j_cyto_2022_156120 crossref_primary_10_3389_fnut_2025_1561271 crossref_primary_10_1016_j_biopha_2023_116022 crossref_primary_10_1016_j_phymed_2025_156402 crossref_primary_10_1016_j_joim_2024_06_001 crossref_primary_10_3390_toxins14120859 crossref_primary_10_1371_journal_pone_0314029 crossref_primary_10_1080_1828051X_2023_2297557 crossref_primary_10_1080_0886022X_2025_2506810 crossref_primary_10_1097_MD_0000000000040975 crossref_primary_10_3389_fphar_2025_1517047 crossref_primary_10_3389_fnut_2022_890730 crossref_primary_10_1093_jpp_rgac024 crossref_primary_10_3389_fimmu_2024_1362642 crossref_primary_10_1021_acs_jafc_5c01260 crossref_primary_10_1016_j_aninu_2024_05_011 crossref_primary_10_3389_fphar_2022_1068613 crossref_primary_10_3389_fimmu_2021_813890 crossref_primary_10_1016_j_micpath_2025_108026 crossref_primary_10_1039_D1FO04178A crossref_primary_10_1016_j_foodchem_2024_140514 crossref_primary_10_2147_DDDT_S389811 crossref_primary_10_3390_nu14132666 |
| Cites_doi | 10.1080/13880209.2020.1809462 10.1128/CVI.13.2.219-226.2006 10.1186/gb-2011-12-6-r60 10.1007/s00467-016-3527-x 10.3389/fbioe.2020.00299 10.1007/s00424-020-02352-x 10.1111/bcpt.12817 10.1126/science.1171700 10.1159/000484920 10.3390/toxins10070298 10.1038/nature04516 10.1159/000450619 10.1016/j.cca.2013.02.008 10.1038/s12276-019-0234-2 10.1186/s12891-019-2519-y 10.1186/2047-783X-18-26 10.1371/journal.pone.0223445 10.1038/ki.2012.345 10.1186/1471-2369-15-36 10.1016/j.biocel.2018.01.001 10.1186/s12906-015-0644-1 10.1208/s12248-012-9432-8 10.1111/1750-3841.13793 10.1016/j.jhep.2015.04.018 10.1371/journal.pntd.0007444 10.1097/MIB.0000000000000522 10.1016/j.anaerobe.2013.06.012 10.1038/nrgastro.2017.20 10.1016/j.bpg.2003.10.003 10.1038/s41598-017-02989-2 10.1155/2015/505878 10.1111/j.1365-2982.2012.01921.x 10.1002/art.30520 10.1073/pnas.0812874106 10.1038/nmeth.2604 10.1007/s12275-018-8049-8 10.1038/nmicrobiol.2017.26 10.1016/j.jnutbio.2020.108515 10.1038/srep33052 10.1093/ndt/gfq580 10.1007/s11695-012-0655-7 10.1186/1476-4598-10-12 10.3109/09637486.2015.1064869 10.1016/j.fct.2011.10.070 10.14715/cmb/2017.63.7.3 10.1007/s11906-017-0727-0 10.1080/21688370.2018.1425085 10.1093/ndt/gfu287 10.1007/s00216-012-5929-3 10.1016/j.jconrel.2013.06.032 10.1080/00365520701864627 10.1155/2015/535686 10.1016/j.biopha.2017.07.123 10.3390/jcm7100315 10.1186/1471-2458-4-9 10.1042/CS20180563 10.1016/j.redox.2013.09.003 10.1097/HJH.0b013e328312c8c1 10.2215/CJN.03150318 10.1016/j.jare.2016.11.004 10.1053/j.ajkd.2017.12.009 10.1007/978-0-387-46401-5_20 10.1016/j.apsb.2019.10.007 10.1007/s00018-019-03155-9 10.1007/978-981-10-8684-7_9 10.1016/bs.aambs.2016.06.002 |
| ContentType | Journal Article |
| Copyright | 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 The Author(s) |
| Copyright_xml | – notice: 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 – notice: 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 The Author(s) |
| DBID | 0YH AAYXX CITATION 3V. 7T5 7X7 7XB 88E 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 K9. M0S M1P M2O MBDVC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI Q9U 7X8 5PM DOA |
| DOI | 10.1080/0886022X.2021.1944875 |
| DatabaseName | Taylor & Francis Open Access CrossRef ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Local Electronic Collection Information ProQuest Central (subscription) ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database Research Library (subscription) Research Library (Corporate) ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 0YH name: Taylor & Francis Open Access url: https://www.tandfonline.com sourceTypes: Publisher – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | X. Xu et al |
| EISSN | 1525-6049 |
| EndPage | 1075 |
| ExternalDocumentID | oai_doaj_org_article_7594bdcc911a4e91a0867dfada1e33b8 PMC8253186 10_1080_0886022X_2021_1944875 1944875 |
| Genre | Research Article |
| GroupedDBID | --- 00X 0YH 123 29P 36B 4.4 53G 5RE 7X7 88E 8FI 8FJ 8G5 ABDBF ABUWG ACGEJ ACGFS ACUHS ADBBV ADCVX ADRBQ ADXPE AENEX AFKRA AFKVX AJWEG ALMA_UNASSIGNED_HOLDINGS AOIJS AQTUD ARJSQ AZQEC BABNJ BCNDV BENPR BLEHA CCPQU CS3 DWQXO EAP EBC EBD EBS EMB EMK EMOBN EPL ESX F5P FYUFA GNUQQ GROUPED_DOAJ GUQSH H13 HMCUK HZ~ M1P M2O M4Z O9- P2P PHGZM PHGZT PIMPY PJZUB PPXIY PROAC PSQYO RPM SV3 TDBHL TFDNU TFL TFW TUS UKHRP V1S ~1N AAYXX AFFHD CITATION 3V. 7T5 7XB 8FK H94 K9. MBDVC PKEHL PQEST PQQKQ PQUKI Q9U 7X8 5PM |
| ID | FETCH-LOGICAL-c539t-bb1b66091c41711589dc8650d23f81ac710e738d58aeaf5bef767c10c71290eb3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 74 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000668370900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0886-022X 1525-6049 |
| IngestDate | Fri Oct 03 12:51:01 EDT 2025 Tue Nov 04 01:40:56 EST 2025 Sun Nov 09 10:22:12 EST 2025 Tue Oct 07 07:08:06 EDT 2025 Tue Nov 18 21:56:50 EST 2025 Sat Nov 29 02:26:00 EST 2025 Mon Oct 20 23:46:41 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | open-access: http://creativecommons.org/licenses/by/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c539t-bb1b66091c41711589dc8650d23f81ac710e738d58aeaf5bef767c10c71290eb3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://doaj.org/article/7594bdcc911a4e91a0867dfada1e33b8 |
| PMID | 34187292 |
| PQID | 2721097794 |
| PQPubID | 3933335 |
| PageCount | 13 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_7594bdcc911a4e91a0867dfada1e33b8 crossref_primary_10_1080_0886022X_2021_1944875 crossref_citationtrail_10_1080_0886022X_2021_1944875 proquest_journals_2721097794 informaworld_taylorfrancis_310_1080_0886022X_2021_1944875 proquest_miscellaneous_2546980162 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8253186 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-01-01 |
| PublicationDateYYYYMMDD | 2021-01-01 |
| PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | New York |
| PublicationPlace_xml | – name: New York |
| PublicationTitle | Renal failure |
| PublicationYear | 2021 |
| Publisher | Taylor & Francis Taylor & Francis Ltd Taylor & Francis Group |
| Publisher_xml | – name: Taylor & Francis – name: Taylor & Francis Ltd – name: Taylor & Francis Group |
| References | Long C (CIT0034) 2008; 26 Marzocco S (CIT0058) 2018; 7 CIT0030 CIT0032 CIT0031 CIT0033 Lin B (CIT0029) 2014; 15 Lappan R (CIT0053) 2019; 13 CIT0036 Remedios C (CIT0002) 2012; 22 CIT0038 CIT0037 CIT0041 CIT0040 Guo B (CIT0055) 2019; 14 CIT0001 CIT0045 Liu F (CIT0039) 2017; 44 Chen X (CIT0059) 2020; 8 Chang H (CIT0005) 2001; 28 CIT0003 CIT0047 CIT0049 CIT0004 CIT0048 CIT0007 Martin R (CIT0042) 2012; 50 CIT0009 CIT0008 CIT0050 CIT0052 Conen D (CIT0006) 2004; 4 CIT0010 CIT0054 CIT0012 CIT0056 CIT0011 Sinclair S (CIT0019) 2013; 171 CIT0014 Vaziri N (CIT0046) 1985; 80 CIT0057 CIT0016 CIT0015 CIT0018 CIT0017 CIT0061 CIT0060 CIT0063 CIT0062 CIT0021 CIT0065 CIT0020 Wexler A (CIT0043) 2017; 2 CIT0064 CIT0023 CIT0067 CIT0066 Huang G (CIT0022) 2017; 63 Armani R (CIT0013) 2017; 19 Itoh Y (CIT0051) 2012; 403 Guirong Y (CIT0044) 2018; 38 CIT0025 CIT0069 CIT0024 CIT0068 CIT0027 CIT0026 Amat N (CIT0035) 2015; 15 CIT0028 |
| References_xml | – ident: CIT0037 doi: 10.1080/13880209.2020.1809462 – ident: CIT0065 doi: 10.1128/CVI.13.2.219-226.2006 – ident: CIT0027 doi: 10.1186/gb-2011-12-6-r60 – ident: CIT0069 doi: 10.1007/s00467-016-3527-x – volume: 8 start-page: 299 year: 2020 ident: CIT0059 publication-title: Front Bioeng Biotechnol doi: 10.3389/fbioe.2020.00299 – ident: CIT0010 doi: 10.1007/s00424-020-02352-x – ident: CIT0015 doi: 10.1111/bcpt.12817 – ident: CIT0028 doi: 10.1126/science.1171700 – volume: 44 start-page: 401 issue: 1 year: 2017 ident: CIT0039 publication-title: Cell Physiol Biochem doi: 10.1159/000484920 – ident: CIT0014 doi: 10.3390/toxins10070298 – ident: CIT0031 doi: 10.1038/nature04516 – ident: CIT0045 doi: 10.1159/000450619 – ident: CIT0050 doi: 10.1016/j.cca.2013.02.008 – ident: CIT0063 doi: 10.1038/s12276-019-0234-2 – ident: CIT0030 doi: 10.1186/s12891-019-2519-y – volume: 80 start-page: 608 issue: 8 year: 1985 ident: CIT0046 publication-title: Am J Gastroenterol – ident: CIT0032 doi: 10.1186/2047-783X-18-26 – volume: 38 start-page: 1401 issue: 12 year: 2018 ident: CIT0044 publication-title: Nan Fang Yi Ke Da Xue Xue Bao – volume: 14 start-page: e0223445 issue: 10 year: 2019 ident: CIT0055 publication-title: PloS One doi: 10.1371/journal.pone.0223445 – ident: CIT0054 doi: 10.1038/ki.2012.345 – volume: 15 start-page: 36 issue: 1 year: 2014 ident: CIT0029 publication-title: BMC Nephrol doi: 10.1186/1471-2369-15-36 – ident: CIT0036 doi: 10.1016/j.biocel.2018.01.001 – volume: 15 start-page: 131 year: 2015 ident: CIT0035 publication-title: BMC Complement Altern Med doi: 10.1186/s12906-015-0644-1 – ident: CIT0021 doi: 10.1208/s12248-012-9432-8 – ident: CIT0017 doi: 10.1111/1750-3841.13793 – ident: CIT0018 doi: 10.1016/j.jhep.2015.04.018 – volume: 13 start-page: e0007444 issue: 9 year: 2019 ident: CIT0053 publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0007444 – ident: CIT0024 doi: 10.1097/MIB.0000000000000522 – ident: CIT0057 doi: 10.1016/j.anaerobe.2013.06.012 – ident: CIT0008 doi: 10.1038/nrgastro.2017.20 – ident: CIT0049 doi: 10.1016/j.bpg.2003.10.003 – ident: CIT0056 doi: 10.1038/s41598-017-02989-2 – ident: CIT0064 doi: 10.1155/2015/505878 – volume: 28 start-page: 1640 issue: 7 year: 2001 ident: CIT0005 publication-title: J Rheumatol – ident: CIT0067 doi: 10.1111/j.1365-2982.2012.01921.x – ident: CIT0007 doi: 10.1002/art.30520 – ident: CIT0048 doi: 10.1073/pnas.0812874106 – ident: CIT0026 doi: 10.1038/nmeth.2604 – ident: CIT0009 doi: 10.1007/s12275-018-8049-8 – volume: 2 start-page: 17026 year: 2017 ident: CIT0043 publication-title: Nat Microbiol doi: 10.1038/nmicrobiol.2017.26 – ident: CIT0038 doi: 10.1016/j.jnutbio.2020.108515 – ident: CIT0041 doi: 10.1038/srep33052 – ident: CIT0052 doi: 10.1093/ndt/gfq580 – volume: 22 start-page: 945 issue: 6 year: 2012 ident: CIT0002 publication-title: Obes Surg doi: 10.1007/s11695-012-0655-7 – ident: CIT0016 doi: 10.1186/1476-4598-10-12 – ident: CIT0066 doi: 10.3109/09637486.2015.1064869 – volume: 50 start-page: 227 issue: 2 year: 2012 ident: CIT0042 publication-title: Food Chem Toxicol doi: 10.1016/j.fct.2011.10.070 – volume: 63 start-page: 20 issue: 7 year: 2017 ident: CIT0022 publication-title: Cell Mol Biol (Noisy-le-Grand) doi: 10.14715/cmb/2017.63.7.3 – volume: 19 start-page: 29 issue: 4 year: 2017 ident: CIT0013 publication-title: Curr Hypertens Rep doi: 10.1007/s11906-017-0727-0 – ident: CIT0023 doi: 10.1080/21688370.2018.1425085 – ident: CIT0012 doi: 10.1093/ndt/gfu287 – volume: 403 start-page: 1841 issue: 7 year: 2012 ident: CIT0051 publication-title: Anal Bioanal Chem doi: 10.1007/s00216-012-5929-3 – volume: 171 start-page: 38 issue: 1 year: 2013 ident: CIT0019 publication-title: J Control Release doi: 10.1016/j.jconrel.2013.06.032 – ident: CIT0025 doi: 10.1080/00365520701864627 – ident: CIT0033 doi: 10.1155/2015/535686 – ident: CIT0068 doi: 10.1016/j.biopha.2017.07.123 – volume: 7 start-page: 315 issue: 10 year: 2018 ident: CIT0058 publication-title: JCM doi: 10.3390/jcm7100315 – volume: 4 start-page: 4 issue: 1 year: 2004 ident: CIT0006 publication-title: BMC Public Health doi: 10.1186/1471-2458-4-9 – ident: CIT0004 doi: 10.1042/CS20180563 – ident: CIT0020 doi: 10.1016/j.redox.2013.09.003 – volume: 26 start-page: 2326 issue: 12 year: 2008 ident: CIT0034 publication-title: J Hypertens doi: 10.1097/HJH.0b013e328312c8c1 – ident: CIT0047 doi: 10.2215/CJN.03150318 – ident: CIT0003 doi: 10.1016/j.jare.2016.11.004 – ident: CIT0001 doi: 10.1053/j.ajkd.2017.12.009 – ident: CIT0040 doi: 10.1007/978-0-387-46401-5_20 – ident: CIT0060 doi: 10.1016/j.apsb.2019.10.007 – ident: CIT0062 doi: 10.1007/s00018-019-03155-9 – ident: CIT0011 doi: 10.1007/978-981-10-8684-7_9 – ident: CIT0061 doi: 10.1016/bs.aambs.2016.06.002 |
| SSID | ssj0015872 |
| Score | 2.5037327 |
| Snippet | It is well known that the progression of hyperuricemia disease often contributes to renal dysfunction. However, there have been few studies on uric acid... |
| SourceID | doaj pubmedcentral proquest crossref informaworld |
| SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 1063 |
| SubjectTerms | Apoptosis Creatinine Curcumin Digestive system Endotoxemia Fatty acids Fibrosis Gastrointestinal tract Gut microbiota Hyperuricemia Inflammation intestinal barrier Intestinal microflora Intestine Laboratory Study Metabolism Microbiota Nephropathy Next-generation sequencing Opportunist infection Renal function Uric acid uric acid nephropathy |
| SummonAdditionalLinks | – databaseName: ProQuest Central (subscription) dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwELVgixAXvhGBgozENWWTOBv7hGjVigurCoG0t2CPnRKpmyz5QOLfM5M4y4YDPXCN48TRPNvPY-c9xt6mOgGnAEKT6CIUJlKhVksXGqFAOaciUcjBbCJbr-Vmoy59wq31xyqnMXEYqG0NlCN_F-NSZYlkRYn3ux8huUbR7qq30LjNjkipTCzY0en5-vLzfh8hlYN9E3YlOmobb6Z_eEhdW5L9UrzBNWIcnWBlMRw2PJidBhH_vyRMZ0R0fozyYF66ePC_X_SQ3feMlH8YIfSI3XLVY3b3k99zf8K-nfUN9Nuy4tvaktmXa_lV3_FtOWo4dZrryvJyyE5gWePocTRfUsw51kOQtZwSvpwkjLiG0vLK7cigAfnnr6fs68X5l7OPofdlCCFNVBcaE5nVCokGiChDRimVBYlMz8ZJISMNSFpclkibSu10kRpXZKsMoiUWxIgDkzxji6qu3HPGE-sUKcYDQCoEpAqhQWtAsBIhI0zAxBSPHLxoOXlnXOfRpG3qw5hTGHMfxoCd7KvtRtWOmyqcUrD3N5Po9nChbq5y34fzDJtnLADOD1ogjDUuBzNbaKsjlyRGBkwdQiXvhpxLMRqk5MkNDTieQJL7UaTN_yAkYG_2xdj_aVNHV67u8Z6UPECRuMcBy2Z4nH3MvKQqvw9K4jLGIViuXvz75S_ZPWrqmHg6Zouu6d0rdgd-dmXbvPZd7jfsnjMT priority: 102 providerName: ProQuest – databaseName: Taylor & Francis Journals Complete dbid: TFW link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQhRAX3ojQgozENWUTO4l9hIoVFyoORezN2GOnRGKz1SZB4t93JnFWDRLqAY6JM4kf45lvbOcbxt4WVkDQAKkTtk6ly3Rq9SqkTmrQIehM1mpMNlGdn6vNRn-Jpwm7eKySYuh6IooYbTVNbuu6-UTcO5wYJbqeDUZ3eXaKUTiBbrTC6Poph8HF-tthH6FQY_omkkhJZP6H529vWXinkcT_DwrTBRBdHqO84ZfWD_9Dix6xBxGU8veTFj1md0L7hN37HLfdn7LvZ8Mehm3T8u3OU76v0PHLoefbZqJx6i3HT_NmXKDAsn2g15HLpGHnKId61nFa8-XEYsQtNJ634YpyNCAE_f2MfV1_vDj7lMbUDCkUQvepc5krS8QaILMKQaXSHhSCPZ-LWmUWELeESihfKBtsXbhQV2UF2QoLclQFJ56zo3bXhheMCx80kcYDQCElFBq1g8JA8Aq1RrqEyXlIDETeckqf8dNkM71p7D1DvWdi7yXs9CB2NRF33Cbwgcb78DDxbo83dvtLE6exqbB6zgOgi7ASNdliRFj52nqbBSGcSpi-qS2mH5dd6ilHihG3VOBkVi0TDUlncozQV4jRtUzYm0MxmgDa17Ft2A34TEFpQBG75wmrFiq5aMyypG1-jGTiKkcrrMqX_1DxY3afLqeFqRN21O-H8IrdhV990-1fjxPyGhAzNFg priority: 102 providerName: Taylor & Francis |
| Title | Curcumin modulates gut microbiota and improves renal function in rats with uric acid nephropathy |
| URI | https://www.tandfonline.com/doi/abs/10.1080/0886022X.2021.1944875 https://www.proquest.com/docview/2721097794 https://www.proquest.com/docview/2546980162 https://pubmed.ncbi.nlm.nih.gov/PMC8253186 https://doaj.org/article/7594bdcc911a4e91a0867dfada1e33b8 |
| Volume | 43 |
| WOSCitedRecordID | wos000668370900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1525-6049 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0015872 issn: 0886-022X databaseCode: DOA dateStart: 20160101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1525-6049 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0015872 issn: 0886-022X databaseCode: 7X7 dateStart: 20171101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1525-6049 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0015872 issn: 0886-022X databaseCode: BENPR dateStart: 20171101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1525-6049 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0015872 issn: 0886-022X databaseCode: PIMPY dateStart: 20171101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Research Library customDbUrl: eissn: 1525-6049 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0015872 issn: 0886-022X databaseCode: M2O dateStart: 20171101 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest – providerCode: PRVAWR databaseName: Taylor & Francis Journals Complete customDbUrl: eissn: 1525-6049 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0015872 issn: 0886-022X databaseCode: TFW dateStart: 20170101 isFulltext: true titleUrlDefault: https://www.tandfonline.com providerName: Taylor & Francis – providerCode: PRVAWR databaseName: Taylor & Francis Open Access customDbUrl: eissn: 1525-6049 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0015872 issn: 0886-022X databaseCode: 0YH dateStart: 19870101 isFulltext: true titleUrlDefault: https://www.tandfonline.com providerName: Taylor & Francis |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nj9MwELVgQYgL4lMElspIXLM0iVPbR3a11XJoqdAisifjryyRaLpqEyT-PTNOUjVceuFiKXEcxZmZ-I3tvEfIh1xn1ktrY5PpMmYmkbGWUx8bJq30XiasFEFsgi-Xoijk6kDqC_eEdfTA3Yv7yHPJjLMWglIzaKsBg3NXaqcTn2Um_OYLqGdIpvr1g1wE2SYIIdximxbDvzvIqi1QdiktIDdMkzPI4VnYZHgwKgXy_n-oS0cAdLx98mA8mj8lT3ogST91HXhG7vn6OXm06JfKX5AfF-3WtuuqpuuNQ40uv6O3bUPXVUe91Giqa0erMKkAdVuPt8NhDk1FoR34xo7iPC1F5iGqbeVo7e9QVwFg45-X5Nv88vriKu7lFGKbZ7KJjUnMbAb4wLKEAxAU0lkBAM2lWSkSbQFreJ4JlwvtdZkbX_IZt8kUKlIwn8lekZN6U_vXhGbOSyR6t9bmjFkwUSkwdbNOgKWZiQgbXqeyPdc4Sl78UslASdpbQaEVVG-FiJztm911ZBvHGpyjrfYXI1d2OAEepHoPUsc8KCLy0NKqCVMlZadrorIjD3A6uIXqg3-nUsiqp4CrJYvI-301hC2uxejab1q4JkfpTsDbaUT4yJ1GnRnX1NXPQAAOWT18imdv_kfv35LH2KFuVumUnDTb1r8jD-3vptptJ-T-9OYKSl7wUIoJeXB-uVx9nYR4g3KRfoFzq8-L1Q0cXc-__wUpDSx7 |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6VgoALb9RAgUWCo9vYXse7B4SgULVqG3EoUm7bfblYapyQ2KD-KX4jM36EmAM99cA1693s2t88PZ4P4E2iY-ultYGJdRZwE8pAy6EPDJdWei9DnomabCIdj8VkIr9swK_uWxgqq-x0Yq2o3cxSjnw3wlBliM6K5O_n3wNijaK3qx2FRgOLI3_5E0O25bvDT_h830bR_ufTvYOgZRUIbBLLMjAmNKMRmknLwxT9ISGdFeinuCjORKgtmlyfxsIlQnudJcZn6Si14RAHIjyFiXHdG3AT9XhKJWTpZBXg4Vo1WRQKLhX2RpPuiyHq5S2I7CmaYEQahTuh5LwubVyzhTVlwF8NU3tub79oc80K7t__3-7fA7jX-tvsQyMgD2HDF4_g9klbUfAYzvaqha2mecGmM0dUZn7JzquSTfOmQ1WpmS4cy-vcC44tPC1H3gAhmuE8FKElo3Q2owZNTNvcscLPiX4CvevLJ_D1Ws73FDaLWeG3gMXOS-qHb61NOLeJROBThGudQIHgZgC8e_7Kti3ZiRnkQoVd59YWNopgo1rYDGBnNW3e9CS5asJHAtfqYmopXv8wW5yrVkOpFLdnnLVo_TRHIdUY7KYu006HPo6NGIBch6Yq64xS1tC_qPiKDWx3oFStjlyqP4gcwOvVMGo3emWlCz-r8JqEGE4xLIkGkPbw3ztMf6TIv9V90kWEBkaMnv37z1_BnYPTk2N1fDg-eg53adtNim0bNstF5V_ALfujzJeLl7WwMzi7bun4DfCVjb0 |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagoIoLb0SggJG4pmxiJ7GPUFiBgFUPRezN-JU2Eptd5YHEv2cmcVYNEuoBrpmM48fY843tfEPIq0wz66W1sWG6jLlJZKzlwseGSyu9lwkvxZBsolitxHotT8NtwjZcq8QYuhyJIoa1Gif3zpXTjbjXMDFycD1riO7S5BiicATd18kNgM45xl9ny2_7g4RMDPmbUCVGneknnr8VM3NPA4v_HxymMyQ6v0d5yTEt7_yHJt0ltwMqpW9GM7pHrvn6Pjn8Es7dH5DvJ31j-01V083WYcIv39LzvqObauRx6jSFT9Nq2KEAWeOxOPSZOO4U9MDQWoqbvhRpjKi2laO132GSBsCgvx6Sr8v3Zycf4pCbIbYZk11sTGLyHMCG5UkBqFJIZwWgPZeyUiTaAnDxBRMuE9rrMjO-LPLCJgsQpGALhj0iB_W29o8JZc5LZI231mac20yCeWAcaJ0As-EmInwaEmUDcTnmz_ihkonfNPSewt5TofcicrxX243MHVcpvMXx3r-MxNvDg21zrsI8VgVUzzhrwUdoDqasISQsXKmdTjxjRkREXrYW1Q37LuWYJEWxKypwNJmWCitJq1II0RcA0iWPyMu9GNYAPNjRtd_28E6GeUABvKcRKWYmOWvMXFJXFwObuEhhGRb5k3-o-AtyePpuqT5_XH16Sm6hZNykOiIHXdP7Z-Sm_dlVbfN8mJu_AZzGNzQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Curcumin+modulates+gut+microbiota+and+improves+renal+function+in+rats+with+uric+acid+nephropathy&rft.jtitle=Renal+failure&rft.au=Xu%2C+Xueling&rft.au=Wang%2C+Huifang&rft.au=Guo%2C+Dandan&rft.au=Man%2C+Xiaofei&rft.date=2021-01-01&rft.issn=0886-022X&rft.eissn=1525-6049&rft.volume=43&rft.issue=1&rft.spage=1063&rft.epage=1075&rft_id=info:doi/10.1080%2F0886022X.2021.1944875&rft.externalDBID=n%2Fa&rft.externalDocID=10_1080_0886022X_2021_1944875 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0886-022X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0886-022X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0886-022X&client=summon |